Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial treatment for people living with HIV

By sjmartinez • May 22, 2025

Zheng Y, Currier JS, Hughes MD. Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial treatment for people living with HIV. Clin Trials. 2025 May 22:17407745251338558. doi: 10.1177/17407745251338558. Epub ahead of print. PMID: 40400339.

Tags: Heterogeneity of treatment effect, Infectious Diseases, Publications, Randomized clinical trial, subgroup

Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials

Møller Jensen C, Zargari Marandi R, Moestrup KS, Mourad A, Mena Lora AJ, Sherman BT, Vock DM, Nordwall JA, Carson JM, Peiffer-Smadja N, Aggarwal NR,[...]

Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study

Bach E, Breschi A, Wang Y, Carroll MK, Luk W, Han A, Short S, Cimermančič P, Drake KA, Cook LJ, Snyder T, Smith TJ, Yeaman[...]

Bundibugyo Ebola in DR Congo and Uganda: community-centred response must be operational, not rhetorical

Mbala-Kingebeni P, Boum Y, Fallah MP, Wilson B, Belizaire MR, Hoff NA, Sprecher A, Hensley LE, Kindrachuk J, Rimoin AW. Bundibugyo Ebola in DR Congo[...]